Overview
Myoclonic epilepsy with ragged red fibers (MERRF) is a mitochondrial encephalomyopathy characterized by myoclonus, epilepsy, and ragged-red fibers on muscle biopsy, resulting from mitochondrial DNA mutations affecting tRNA function 1.Diagnosis
Clinical Features: Myoclonus, epilepsy, progressive neurological decline 1.
Muscle Biopsy: Presence of ragged-red fibers indicative of mitochondrial dysfunction 1.
Genetic Testing: Identification of mitochondrial DNA mutations, particularly A8344G in tRNA(Lys) 1.
Imaging: MRI may show characteristic changes in brain morphology 1.Management
Symptomatic Treatment: Anticonvulsants for seizure control (e.g., valproate, levetiracetam) 1.
Supportive Care: Physical and occupational therapy to manage motor deficits 1.
Dietary Management: No specific dietary recommendations based on current evidence 1.Special Populations
Pregnancy: Limited data; close monitoring required due to potential for maternal and fetal complications 1.
Pediatrics: Early intervention with multidisciplinary support crucial for managing developmental delays 1.
Elderly: Focus on palliative care and symptom management as disease progresses 1.
Comorbidities: Management tailored to individual comorbidities with caution due to potential drug interactions 1.Key Recommendations
Genetic Testing for Diagnosis: Confirm diagnosis through genetic testing for mitochondrial DNA mutations, particularly in tRNA(Lys) 1 (Evidence: Strong).
Anticonvulsant Therapy for Seizures: Initiate anticonvulsants to control seizures, considering individual patient response and side effects 1 (Evidence: Moderate).
Multidisciplinary Support: Implement multidisciplinary care including neurology, physiotherapy, and occupational therapy to address motor and cognitive impairments 1 (Evidence: Expert opinion).References
1 Yasukawa T, Suzuki T, Ishii N, Ohta S, Watanabe K. Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. The EMBO journal 2001. link